Theseus Pharmaceuticals, Inc.
THRX
Revenue
0.00
0.000.00%
-Assets
234.63M
▼-10.44M▼-4.26%
3 Months ChangeLiabilities
10.11M
▼-883.00k▼-8.04%
3 Months ChangeFree Cash Flow
-18.63M
▼-10.92M▼-141.60%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-02-14
Form 8-K
ID: 0001104659-24-023155
2023-12-22
Form 8-K
ID: 0001104659-23-128468
2023-12-04
Form 8-K
ID: 0001104659-23-123002
2023-11-27
Form 8-K
ID: 0001104659-23-121095
2023-11-17
Form 10-Q
ID: 0001745020-23-000080
2023-11-13
Form 8-K
ID: 0001745020-23-000073
2023-10-31
Form 8-K
ID: 0001745020-23-000057
2023-08-10
Form 10-Q
ID: 0001745020-23-000050
2023-08-10
Form 8-K
ID: 0001745020-23-000049
2023-07-13
Form 8-K
ID: 0001104659-23-080741